CHT is a leader in the field of biomedical and biotherapeutics research supported by a portfolio of full patents
Patents
Work with CHT
Our patents
- 2012: Nguyen HT, Ghevondian N.
‘A non-invasive method and apparatus for determining onset of physiological conditions’,
European Patent EP 1370276, granted 1710/2012 - 2011: Ghevondian N, Nguyen HT, Wilshire RJ.
‘Patient Monitor’,
Australian Patent No. 2004236368, granted 17/11/2011 - 2010: Ting SRS, Nguyen TLU, Stenzel MH, Gu W.
‘Hollow microparticles’,
European Patent EP 2111418, granted 28/7/2010 - 2010: Ting SRS, Nguyen TLU, Stenzel MH, Gu W.
‘Hollow microparticles’,
US Patent 20100104647, granted 29/4/2010 - 2009: Ghevondian N, Nguyen HT, Wilshire RJ.
‘Patient Monitor’,
European Patent EP1626657, granted 16/9/2009 - 2008: Simpson A, Tao C.
‘Genetically modified cells and uses thereof’,
European Patent EP 20080782908, granted 2008 - 2008: King GF, Sollod McFarland B, Nicholson GM, Gunning SJ.
“Insecticidal Polypeptides and Methods of Use Thereof”,
US Patent No. 7,354,993 B2 Filed March 7, 2008. - 2008: Nguyen HT, Ghevondian N.
‘Non-invasive method and apparatus for determining onset of physiological conditions’,
US Patent 7,450,986 B2, granted 11/11/2008 - 2008: Ting SRS, Nguyen TLU, Stenzel MH, Gu W.
‘Hollow microparticles’,
Australian Patent 2008000158, granted 14/8/2008 - 2005: Nguyen HT, Ghevondian N.
‘Non-invasive method and apparatus for determining onset of physiological conditions’,
New Zealand Patent 527818, granted 9/6/2005 - 2004: Nguyen HT, Ghevondian N.
‘A non-invasive method and apparatus for determining onset of physiological conditions’,
Australian Patent 2002233052, granted 23/9/2004 - 2003: Zamore PD, Schwarz DS, Simard M, Hutvagner G.
‘Methods and compositions for enhancing the efficacy and specificity of applications RNAi’,
US8309704, US7750144, US8309705, EU1633890, 6/2003